Finance

Lists
MGTX:NASDAQ
MeiraGTx Holdings PLC
$13.02
+1.28%
(+0.16) 1D
Sep 11, 9:30:37 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGTX...
Open
$13.04
High
$13.04
Low
$13.00
Mkt. cap
1.25B
Avg. vol.
645.30K
Volume
62.00
P/E ratio
18.44
52-wk high
$15.35
52-wk low
$6.62
EPS
$0.71
Beta
1.27
Shares outstanding
96.04M
No. of employees
393
Open
$13.04
High
$13.04
Low
$13.00
Mkt. cap
1.25B
Avg. vol.
645.30K
Volume
62.00
P/E ratio
18.44
52-wk high
$15.35
52-wk low
$6.62
EPS
$0.71
Beta
1.27
Shares outstanding
96.04M
No. of employees
393
News stories
From web sources and news partners
About MeiraGTx Holdings PLC
CEOAlexandria Forbes
Employees393
Founded2015
HeadquartersNew York, New York, United States
SectorBiotechnology
Websitemeiragtx.com
Analyst ratings
Based on 6 analysts giving stock ratings to MGTX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MGTX in the last 3 months.
Highest
Current $13.02
$30.00 (+130.50%)
Average
$23.20 (+78.26%)
Lowest
$19.00 (+45.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allison Bratzel
Piper Sandler
Buy
Maintained
$30.00
+130.5%
08/17/2026
Lisa Walter
RBC Capital
Buy
Reiterated
$27.00
+107.5%
08/13/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
$19.00
+46%
08/14/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$20.00
+53.7%
08/14/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$20.00
+53.7%
07/09/2026
Luca Issi
RBC Capital
Buy
Maintained
$26.00
+99.8%
07/08/2026
Unknown Analyst
Raymond James
Buy
Maintained
-
-
06/24/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$35.00
+168.9%
05/14/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
$18.00
+38.3%
04/01/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.52 / -$0.42
+697.30%beat
Revenue / Est. (USD)
321.43M / 10.45M
+2,977.12%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
410.00K
75.36M
293.00K
321.43M
Cost of goods sold
313.00K
476.00K
198.00K
7.16M
Cost of revenue
313.00K
476.00K
198.00K
7.16M
Research and development expenses
32.53M
30.81M
31.98M
57.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.62M
17.60M
8.93M
12.01M
Operating expense
46.15M
48.42M
40.91M
69.84M
Total operating expenses
46.46M
48.89M
41.11M
77.01M
Operating income
-46.05M
26.47M
-40.82M
244.42M
Other non operating income
-
-
-
-5.22M
EBT including unusual items
-50.51M
15.09M
-46.31M
163.03M
EBT excluding unusual items
-50.51M
15.09M
-46.31M
163.03M
Income tax expense
-
-
-
2.36M
Effective tax rate
-
-
-
1.45%
Other operating expenses
-
-
-
-
Net income
-50.51M
15.09M
-46.31M
160.72M
Net profit margin
-12,320.24%
20.02%
-15,806.48%
50.00%
Earnings per share
-0.62
0.19
-0.57
2.52
Interest and investment income
161.00K
278.00K
189.00K
706.00K
Interest expense
-3.06M
-3.06M
-2.85M
-3.51M
Net interest expenses
-2.90M
-2.78M
-2.66M
-2.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.90M
29.59M
-37.81M
247.25M
Gain or loss from assets sale
432.00K
45.00K
55.00K
-9.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps